Butterfly Network, a global player in democratizing medical imaging, to be listed on NYSE through a merger with Longview Acquisition.

  • Butterfly Network’s mission is to enable universal access to superior medical imaging, making high quality ultrasound affordable, easy-to-use, globally accessible and intelligently connected.
  • Butterfly iQ is the only ultrasound transducer that can perform “whole-body imaging” with a single handheld probe using semiconductor technology. Connected to a mobile phone or tablet, it is powered by Butterfly’s proprietary Ultrasound-on-Chip™ technology and harnesses the advantages of AI to deliver advanced imaging that we believe is easy-to-use, improves patient outcomes and lowers cost of care.
  • This transaction is expected to drive further adoption of Butterfly Network’s breakthrough solutions and accelerate its future pipeline of innovative technologies.
  • The Pro Forma enterprise value of the merger is $1.5 billion, with the combined company expected to have an estimated $584 million in cash after closing.
  • Founder Dr. Jonathan Rothberg to become Chairman of the combined company and will be Butterfly’s largest controlling shareholder.
  • 100% of the equity of existing Butterfly Network investors, including Baillie Gifford, The Bill & Melinda Gates Foundation and Fosun Industrial,
    Limited, will convert into shares of the combined company. There will be no selling stockholders in the transaction.
  • Longview is an affiliate of healthcare investment firm Glenview Capital Management, which is expected to own, along with its affiliates, 7.6% of the combined company’s outstanding shares at closing. Longview Chair and Glenview CEO, Larry Robbins, will join the Board of the combined company. Institutional investors including Eldridge, Fidelity Management & Research  Company, Glenview, Ridgeback, Tenet Healthcare, UPMC Enterprises and Wellington Management have anchored a $175 million PIPE at $10 per share.
  • The business combination is expected to be completed by the end of the first quarter of 2021, and the combined company will be listed on the NYSE under ticker symbol “BFLY.”
  • A webcast to present the proposed transaction is available on

Butterfly Network, an innovative digital health company that is working to enable universal access to superior medical imaging, and Longview Acquisition, a special purpose acquisition company sponsored by Glenview Capital Management, announced that they have entered into a definitive business combination agreement. Upon closing, the combined company’s Class A common stock is expected to be traded on the New York Stock Exchange (“NYSE”) under the symbol “BFLY.”